Premium
Severe COVID ‐19 and interleukin‐6 receptor antagonist tocilizumab: Some notes of concern
Author(s) -
Akinosoglou Karolina,
Gogos Charalambos
Publication year - 2020
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13939
Subject(s) - tocilizumab , medicine , covid-19 , interleukin 1 receptor antagonist , receptor antagonist , antagonist , interleukin , virology , interleukin 6 , receptor , immunology , cytokine , rheumatoid arthritis , disease , outbreak , infectious disease (medical specialty)
See related reply
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom